Results 221 to 230 of about 55,987 (284)

Probability of achieving bone mineral density treatment targets with abaloparatide and teriparatide. [PDF]

J Bone Miner Res
Cosman F, Mitlak BH, Wang Y, Pearman L, Moreira CA, Lewiecki EM, Cummings SR.   +6 more
europepmc   +1 more source

Plasticity in climate change responses

Biological Reviews, EarlyView.
ABSTRACT Recent research has shown that climate change can both induce and modulate the expression of plastic traits but our understanding of the role of phenotypic plasticity as an adaptive response to climate change is limited. In this review, we dissect the mechanisms and impact of phenotypic plasticity as a response to accumulating climatic ...
Angelika Stollewerk, Pavel Kratina, Arnaud Sentis, Catalina Chaparro‐Pedraza, Ellen Decaestecker, Luc De Meester, Ozge Eyice, Lynn Govaert, John Iwan Jones, Christian Laforsch, Carolina Madeira, Anita Narwani, Vicencio Oostra, Joost A. M. Raeymaekers, Axel G. Rossberg, Matthias Schott, Robby Stoks, Ellen van Velzen, David Boukal   +18 more
wiley   +1 more source

Patterns of adjuvant bone modifying agent use in patients with early-stage breast cancer in the United States. [PDF]

Breast Cancer Res
Odzer N, Chehayeb RJ, Schellhorn SE, Lustberg M, Gross CP, Lee D, Foldi J.   +6 more
europepmc   +1 more source

Severe hypercalcemia requiring emergency hemodialysis and multidrug therapy in a case of diffuse large B-cell lymphoma with multiple bone lesions. [PDF]

BMC Nephrol
Watanabe Y, Kaneko S, Yamamoto R, Ogishi T, Okamoto S, Yuyama K, Matsuoka A, Nakamura Y, Ando S, Ito K, Hirai K, Ookawara S, Morishita Y.   +12 more
europepmc   +1 more source

Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility.

J Clin Endocrinol Metab
Stoffers AJ, Mancilla EE, Levine MA, Mayer M, Monk HM, Rosano J, Weber DR.   +6 more
europepmc   +1 more source

Timing optimization of teriparatide dosing for postmenopausal osteoporosis: a randomized controlled trial. [PDF]

J Orthop Surg Res
Wang H, Tao L, Liu D, Yan X, Li H, Song C.   +5 more
europepmc   +1 more source

Impact of anti-osteoporotic treatments on hyperlipidemia risk in osteoporosis patients: evidence from a population-based retrospective cohort study. [PDF]

Eur J Med Res
Hsieh HH, Tien N, Lin CL, Wong WH, Lee WY, Chen CH, Tsai FJ, You BJ, Fang YJ, Lim YP.   +9 more
europepmc   +1 more source

Williams syndrome presenting as infantile hypercalcemia with acute kidney injury: a case report. [PDF]

CEN Case Rep
Park E, Kim SC.
europepmc   +1 more source

Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results. [PDF]

Yonsei Med J
Kuwabara A, Inage K, Yamashita M, Orita S, Eguchi Y, Shiga Y, Inoue M, Suzuki-Narita M, Hishiya T, Arai T, Toshi N, Okuyama K, Tokeshi S, Tashiro S, Ohyama S, Suzuki N, Ohtori S.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MEDICATION-RELATED OSTEONECROSIS OF THE JAW: A REVIEW STUDY

Revista contemporânea
Osteonecrosis of the jaws, related to the use of medications, is a condition that can arise because of therapies with antiresorptive drugs, such as bisphosphonates and Denosumab, or with antiangiogenic agents. Although not very common, this condition can
Waléria Pinheiro de Araújo, Lara Oliveira de Jesus, Roberta Oliveira Volponi, Renan Rodrigues Silva, Kamylla Carvalho de Souza, Fernanda Ladim Cruz, Eduardo Lins de Araújo, Vilmar Santos de Almeida, Pedro dos Santos Anjo e Aguero, Sâmyla Amanda Rodrigues dos Santos, Larissa Pinheiro Silva, Antônia Camila Farias, Hellen Anny Ricarte Leite, Alane Raiane Soares Mendonça   +13 more
semanticscholar   +1 more source